-
公开(公告)号：IL289365D0
公开(公告)日：2022-02-01
申请号：IL28936521
申请日：2021-12-24
Applicant: ABBVIE INC , ABBVIE DEUTSCHLAND , LABKVOSKY BORIS , BARGHORN STEFAN , HILLEN HEINZ , EBERT ULRICH , STRIEBINGER ANDREAS R , KELLER PATRICK
Inventor： LABKVOSKY BORIS , BARGHORN STEFAN , HILLEN HEINZ , EBERT ULRICH , STRIEBINGER ANDREAS R , KELLER PATRICK
IPC: A61K39/395 , A61K39/00 , A61P25/28 , A61P37/04 , C07K16/18 , G01N33/577 , G01N33/68
Abstract: The subject invention relates to monoclonal antibodies (e.g., 8F5 and 8C5) that may be used, for example, in the prevention, treatment, and diagnosis of Alzheimer's Disease or other neurodegenerative disorders.
-
公开(公告)号：IL297746A
公开(公告)日：2022-12-01
申请号：IL29774622
申请日：2022-10-27
Applicant: ABBVIE INC , ABBVIE DEUTSCHLAND , LABKVOSKY BORIS , BARGHORN STEFAN , HILLEN HEINZ , EBERT ULRICH , STRIEBINGER ANDREAS R , KELLER PATRICK
Inventor： LABKVOSKY BORIS , BARGHORN STEFAN , HILLEN HEINZ , EBERT ULRICH , STRIEBINGER ANDREAS R , KELLER PATRICK
IPC: A61K39/395 , A61K39/00 , A61P25/28 , A61P37/04 , C07K16/18 , G01N33/577 , G01N33/68
Abstract: The subject invention relates to monoclonal antibodies (e.g., 8F5 and 8C5) that may be used, for example, in the prevention, treatment, and diagnosis of Alzheimer's Disease or other neurodegenerative disorders.
-
公开(公告)号：WO2007064972A2
公开(公告)日：2007-06-07
申请号：PCT/US2006/046148
申请日：2006-11-30
Applicant: ABBOTT LABORATORIES , ABBOTT GMBH & CO. KG , LABKVOSKY, Boris , BARGHORN, Stefan , HILLEN, Heinz , EBERT, Ulrich , STRIEBINGER, Andreas, R. , KELLER, Patrick
Inventor： LABKVOSKY, Boris , BARGHORN, Stefan , HILLEN, Heinz , EBERT, Ulrich , STRIEBINGER, Andreas, R. , KELLER, Patrick
IPC: C07K16/00
CPC classification number: C07K16/18 , A61K2039/505 , C07K2317/14 , C07K2317/20 , C07K2317/21 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/92 , G01N33/577 , G01N33/6896 , G01N2333/4709 , G01N2500/20 , G01N2800/2821
Abstract: The subject invention relates to monoclonal antibodies (e.g., 8F5 and 8C5) that may be used, for example, in the prevention, treatment and diagnosis of Alzheimer's Disease or other neurodegenerative disorders.
Abstract translation: 本发明涉及可用于例如预防，治疗和诊断阿尔茨海默病或其它神经变性疾病的单克隆抗体（例如8F5和8C5）。
-
4.发明申请HUMANIZED ANTIBODIES WHICH BIND TO Aß (1-42) GLOBULOMER AND USES THEREOF 审中-公开人体抗体（1-42）GLOBULOMER及其用途
公开(公告)号：WO2008150946A1
公开(公告)日：2008-12-11
申请号：PCT/US2008065199
申请日：2008-05-30
Applicant: ABBOTT LAB , ABBOTT GMBH & CO KG , HILLEN HEINZ , BARGHORN STEFAN , LABKOVSKY BORIS , EBERT ULRICH , STRIEBINGER ANDREAS R , KELLER PATRICK , HINTON PAUL R , JUAN VERONICA M
Inventor： HILLEN HEINZ , BARGHORN STEFAN , LABKOVSKY BORIS , EBERT ULRICH , STRIEBINGER ANDREAS R , KELLER PATRICK , HINTON PAUL R , JUAN VERONICA M
IPC: C07K16/18
CPC classification number: C07K16/18 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/567
Abstract: The present invention relates to binding proteins and, in particular, humanized antibodies that may be used, for example, in the diagnosis, treatment and prevention of Alzheimer's Disease and related conditions.
Abstract translation: 本发明涉及结合蛋白质，特别是涉及可用于例如阿尔茨海默病和相关病症的诊断，治疗和预防的人源化抗体。
-
公开(公告)号：WO2008067464A2
公开(公告)日：2008-06-05
申请号：PCT/US2007/085932
申请日：2007-11-29
Applicant: ABBOTT LABORATORIES , BARGHORN, Stefan , HILLEN, Heinz , STRIEBINGER, Andreas, R. , LABKOVSKY, Boris , EBERT, Ulrich , KELLER, Patrick
Inventor： BARGHORN, Stefan , HILLEN, Heinz , STRIEBINGER, Andreas, R. , LABKOVSKY, Boris , EBERT, Ulrich , KELLER, Patrick
IPC: A61K39/395
CPC classification number: C07K16/18 , C07K2317/10 , C07K2317/14 , C07K2317/24 , C07K2317/34 , C07K2317/565 , C07K2317/92 , G01N33/6896 , G01N2800/2821
Abstract: The subject invention relates to monoclonal antibodies that may be used in the treatment and diagnosis of Alzheimer's Disease. In particular, the present invention relates to monoclonal antibodies referred to as 10F4 and 3C5 and to other monoclonal antibodies (e.g., murine, human or humanized) having similar properties thereto.
Abstract translation: 本发明涉及可用于治疗和诊断阿尔茨海默病的单克隆抗体。 特别地，本发明涉及称为10F4和3C5的单克隆抗体以及与其具有相似性质的其它单克隆抗体（例如鼠，人或人源化）。
-
Patent Agency Ranking
公开(公告)号：WO2008150946A8
公开(公告)日：2008-12-11
申请号：PCT/US2008/065199
申请日：2008-05-30
Applicant: ABBOTT LABORATORIES , ABBOTT GMBH & CO. KG , HILLEN, Heinz , BARGHORN, Stefan , LABKOVSKY, Boris , EBERT, Ulrich , STRIEBINGER, Andreas R. , KELLER, Patrick , HINTON, Paul R. , JUAN, Veronica M.
Inventor： HILLEN, Heinz , BARGHORN, Stefan , LABKOVSKY, Boris , EBERT, Ulrich , STRIEBINGER, Andreas R. , KELLER, Patrick , HINTON, Paul R. , JUAN, Veronica M.
IPC: C07K16/18
Abstract: The present invention relates to binding proteins and, in particular, humanized antibodies that may be used, for example, in the diagnosis, treatment and prevention of Alzheimer's Disease and related conditions.
-
公开(公告)号：WO2008067464A9
公开(公告)日：2008-07-31
申请号：PCT/US2007085932
申请日：2007-11-29
Applicant: ABBOTT LAB , BARGHORN STEFAN , HILLEN HEINZ , STRIEBINGER ANDREAS R , LABKOVSKY BORIS , EBERT ULRICH , KELLER PATRICK
Inventor： BARGHORN STEFAN , HILLEN HEINZ , STRIEBINGER ANDREAS R , LABKOVSKY BORIS , EBERT ULRICH , KELLER PATRICK
IPC: A61K39/395
CPC classification number: C07K16/18 , C07K2317/10 , C07K2317/14 , C07K2317/24 , C07K2317/34 , C07K2317/565 , C07K2317/92 , G01N33/6896 , G01N2800/2821
Abstract: The subject invention relates to monoclonal antibodies that may be used in the treatment and diagnosis of Alzheimer's Disease. In particular, the present invention relates to monoclonal antibodies referred to as 10F4 and 3C5 and to other monoclonal antibodies (e.g., murine, human or humanized) having similar properties thereto.
-
8.发明申请
公开(公告)号：WO2008067464A3
公开(公告)日：2008-12-04
申请号：PCT/US2007085932
申请日：2007-11-29
Applicant: ABBOTT LAB , BARGHORN STEFAN , HILLEN HEINZ , STRIEBINGER ANDREAS R , LABKOVSKY BORIS , EBERT ULRICH , KELLER PATRICK
Inventor： BARGHORN STEFAN , HILLEN HEINZ , STRIEBINGER ANDREAS R , LABKOVSKY BORIS , EBERT ULRICH , KELLER PATRICK
IPC: A61K39/395 , A61K31/711 , C12N15/09
CPC classification number: C07K16/18 , C07K2317/10 , C07K2317/14 , C07K2317/24 , C07K2317/34 , C07K2317/565 , C07K2317/92 , G01N33/6896 , G01N2800/2821
Abstract: The subject invention relates to monoclonal antibodies that may be used in the treatment and diagnosis of Alzheimer's Disease. In particular, the present invention relates to monoclonal antibodies referred to as 10F4 and 3C5 and to other monoclonal antibodies (e.g., murine, human or humanized) having similar properties thereto.
Abstract translation: 本发明涉及可用于治疗和诊断阿尔茨海默氏病的单克隆抗体。 具体地说，本发明涉及称为10F4和3C5的单克隆抗体和涉及与其具有相似特性的其他单克隆抗体（例如鼠类，人类或人源化的）。
-
公开(公告)号：WO2007064972A3
公开(公告)日：2007-11-01
申请号：PCT/US2006046148
申请日：2006-11-30
Applicant: ABBOTT LAB , ABBOTT GMBH & CO KG , LABKVOSKY BORIS , BARGHORN STEFAN , HILLEN HEINZ , EBERT ULRICH , STRIEBINGER ANDREAS R , KELLER PATRICK
Inventor： LABKVOSKY BORIS , BARGHORN STEFAN , HILLEN HEINZ , EBERT ULRICH , STRIEBINGER ANDREAS R , KELLER PATRICK
IPC: C07K16/18 , A61K39/395 , A61P25/28 , C12N5/18 , C12N15/13 , G01N33/53 , G01N33/577
CPC classification number: C07K16/18 , A61K2039/505 , C07K2317/14 , C07K2317/20 , C07K2317/21 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/92 , G01N33/577 , G01N33/6896 , G01N2333/4709 , G01N2500/20 , G01N2800/2821
Abstract: The subject invention relates to monoclonal antibodies (e.g., 8F5 and 8C5) that may be used, for example, in the prevention, treatment and diagnosis of Alzheimer's Disease or other neurodegenerative disorders.
Abstract translation: 本发明涉及可用于例如预防，治疗和诊断阿尔茨海默病或其它神经变性疾病的单克隆抗体（例如8F5和8C5）。
-
10.发明申请
公开(公告)号：WO2008150949A1
公开(公告)日：2008-12-11
申请号：PCT/US2008/065205
申请日：2008-05-30
Applicant: ABBOTT LABORATORIES , ABBOTT GMBH & CO. KG , BARGHORN, Stefan , EBERT, Ulrich , HILLEN, Heinz , KELLER, Patrick , STRIEBINGER, Andreas R. , LABKOVSKY, Boris , HINTON, Paul R. , JUAN, Veronica M.
Inventor： BARGHORN, Stefan , EBERT, Ulrich , HILLEN, Heinz , KELLER, Patrick , STRIEBINGER, Andreas R. , LABKOVSKY, Boris , HINTON, Paul R. , JUAN, Veronica M.
CPC classification number: C07K16/18 , A61K2039/505 , C07K2317/24
Abstract: The present invention relates to binding proteins and, in particular, humanized antibodies that may be used, for example, in the diagnosis, treatment and prevention of Alzheimer's Disease and related conditions.
Abstract translation: 本发明涉及结合蛋白质，特别是涉及可用于例如阿尔茨海默病和相关病症的诊断，治疗和预防中的人源化抗体。
-
-
-
-
-
-
-
-
-
Search Results
10
records
(took 0.024 seconds)
